Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| MPM BIOIMPACT LLC | 5.21M | $108.0M | 1.23% | +4.22M | 2026-03-31 |
| Vivo Capital, LLC | 2.67M | $55.0M | 0.63% | +205.9K | 2026-03-31 |
| Artisan Partners Limited Partnership | 2.22M | $46.0M | 0.52% | -1.09M | 2026-03-31 |
| Siren, L.L.C. | 1.86M | $38.0M | 0.44% | -- | 2026-03-31 |
| BAKER BROS. ADVISORS LP | 1.46M | $30.0M | 0.34% | -- | 2026-03-31 |
| ADAR1 Capital Management, LLC | 1.01M | $21.0M | 0.24% | -- | 2026-03-31 |
| PERCEPTIVE ADVISORS LLC | 964.4K | $20.0M | 0.23% | -- | 2026-03-31 |
| Patient Square Capital LP | 693.5K | $14.0M | 0.16% | +334.5K | 2026-03-31 |
| Octagon Capital Advisors LP | 574.2K | $11.0M | 0.14% | -- | 2026-03-31 |
| Ikarian Capital, LLC | 525.0K | $2.0M | 0.12% | -- | 2026-03-31 |
